No clinical studies found
No published clinical study of 5-Amino-1MQ was identified on PubMed. The available record is preclinical research and user reported experience. Reported in the cited paper.
SourceBack to search
Weight LossMetabolic
5-Amino-1MQ
5-Amino-1MQ is a small molecule inhibitor of nicotinamide N-methyltransferase, not a peptide. It is studied for fat metabolism and metabolic regulation, with the published record limited to preclinical work and no human clinical trials.
- Lowest cost / mg
- $0.59/mg
- at ZC Labs
- Vendors listed
- 50
- In stock
- 68 of 74
- listings
- COA reports
- 49
Vendor listings
Compare 5-Amino-1MQ prices.
Show prices as
72 listings · 5-Amino-1MQ
In stock5mgseen 3d ago
In stock10mgseen 6d ago
In stock5mgseen 4d ago
In stock5mgseen 3d ago
In stock10mgseen 4d ago
In stock10mgseen 4d ago
In stock5mgseen 7d ago
In stock50mgseen 6d ago
In stock10mgseen 4d ago
In stock10mgseen 7d ago
In stock10mgseen 3d ago
In stock10mgseen 5d ago
In stock10mgseen 5d ago
In stock10mgseen 6d ago
In stock50mgseen 3d ago
In stock5mgseen 3d ago
In stock5mgseen 4d ago
In stock5mgseen 6d ago
In stock10mgseen 4d ago
In stock10mgseen 5d ago
Overview
What is 5-Amino-1MQ?
5-Amino-1MQ is a small molecule inhibitor of nicotinamide N-methyltransferase, not a peptide. It is studied for fat metabolism and metabolic regulation, with the published record limited to preclinical work and no human clinical trials.
- Fat Metabolism
- Metabolic Health
- Energy
- Longevity
What the research reports
Reported benefits of 5-Amino-1MQ
Outcomes described across the published 5-Amino-1MQ literature and ongoing study. Read each as research context, not a promised result.
- 01
NNMT enzyme inhibition work
Blocks nicotinamide N-methyltransferase, an enzyme involved in energy metabolism and the regulation of adipose tissue. Described in the research record.
- 02
Fat mass preclinical research
Mouse work in diet induced obesity reported reduced fat mass, the finding behind most of the interest in this compound. Reported in research settings.
- 03
Oral administration only use
Taken orally rather than injected, which removes the sterility and injection site concerns that apply to most research compounds. Reported in research settings.
- 04
Nicotinamide pathway effects
Inhibition shifts nicotinamide handling, which is why protocols often suggest spacing it apart from NAD+ precursors. Described in the research record.
- 05
Metabolic target research
NNMT is an emerging target in metabolic research, so the compound is studied as a probe as much as a therapy. Noted across the published research record.
Dosage and protocol
5-Amino-1MQ dosage and protocol
Protocols report 50 to 150 mg once daily, or split across two doses, for 4 to 8 weeks. No human dosing study supports these figures. Figures describe study protocols, not a personal regimen.
- Route
- Oral capsule or powder
- Example range
- 50-150 mg
- Frequency
- Once daily
- Timing
- Morning, or split AM and PM, with or without food. Store sealed.
Clinical evidence
Clinical evidence for 5-Amino-1MQ
The published record for 5-Amino-1MQ, labeled by strength so you can see what is settled and what is emerging.
Preclinical obesity mouse work
Published mouse research from around 2018 reported reduced fat mass in diet induced obese animals after NNMT inhibition by this compound. Reported in the cited paper.
SourceNNMT enzyme target context
Broader NNMT literature covers the enzyme's role in metabolism and its overexpression across several tumour types, relevant context for safety. Reported in the cited paper.
SourceInteractions
How it pairs with other peptides
- NAD+ coenzyme
- NNMT inhibition affects nicotinamide handling, so protocols often space the two apart during the day.
- NMN precursor
- Same consideration as NAD+. Both touch nicotinamide metabolism from opposite ends of the pathway.
- MOTS-c peptide
- Both are marketed for metabolic outcomes, but no research has examined them used together.
- Semaglutide
- No published interaction data. Both target body weight through completely separate mechanisms.
Questions
Frequently asked questions.
What is 5-Amino-1MQ?
5-Amino-1MQ is a peptide compound used in research settings. It is commonly studied for its role in weight loss, metabolic, and many researchers compare supplier quality, purity, and testing data before purchasing.
What are the research benefits of 5-Amino-1MQ?
5-Amino-1MQ is often evaluated for its potential influence on signaling pathways, recovery support, and targeted research applications. Research interest varies by peptide, formulation, and study design, so buyers typically review purity, dose, and independent lab verification before choosing a source.
How does 5-Amino-1MQ work?
Like other research peptides, 5-Amino-1MQ is typically studied for how it interacts with specific biological pathways and receptor systems. In practice, the way it is formulated, dosed, and tested matters as much as the compound itself, which is why verified suppliers and transparent COAs are important.
Is 5-Amino-1MQ for research use only?
Yes, products like 5-Amino-1MQ are generally intended for research, laboratory, or educational use and are not marketed as approved human therapeutics. Always follow local laws, lab safety practices, and institutional requirements before handling or studying any peptide.
What should I look for before buying 5-Amino-1MQ?
Key checks include verified COA data, peptide form and concentration, supplier reputation, stock status, and cost per mg. Comparing pricing and testing records side-by-side helps reduce the risk of buying an under-tested or misrepresented product.
